EP2814798 - METHODS AND COMPOUNDS USEFUL IN THE SYNTHESIS OF OREXIN-2 RECEPTOR ANTAGONISTS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 07.02.2020 Database last updated on 02.09.2024 | |
Former | The patent has been granted Status updated on 01.03.2019 | ||
Former | Grant of patent is intended Status updated on 24.10.2018 | ||
Former | Examination is in progress Status updated on 06.10.2017 | Most recent event Tooltip | 08.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 10.08.2022 [2022/32] | Applicant(s) | For all designated states Eisai R&D Management Co., Ltd. 6-10, Koishikawa 4-chome, Bunkyo-ku Tokyo 112-8088 / JP | [2014/52] | Inventor(s) | 01 /
MONIZ, George, Anthony 700 Huron Avenue, Apt. 18K Cambridge, MA 02138 / US | 02 /
WILCOXEN, Annie, Zhu 18 Peter Road North Reading, MA 01864 / US | 03 /
BENAYOUD, Farid 805 Forest Street North Andover, MA 01845 / US | 04 /
LEE, Jaemoon 57 Argilla Road Andover, MA 01810 / US | 05 /
ZHANG, Huiming 2 Dorset Circle Andover, MA 01810 / US | 06 /
TERAUCHI, Taro c/o Eisai Co., Ltd. Tsukuba Research, Laboratories 1-3 Tokodai 5-chome Tsukuba-shi, Ibaraki / JP | 07 /
TAKEMURA, Ayumi c/o Eisai Co., Ltd. Tsukuba Research, Laboratories 1-3 Tokodai 5-chome Tsukuba-shi, Ibaraki / JP | 08 /
YOSHIDA, Yu c/o Eisai Co., Ltd. Tsukuba Research, Laboratories 1-3 Tokodai 5-chome Tsukuba-shi, Ibaraki / JP | 09 /
TANAKA, Toshiaki c/o Eisai Co., Ltd. Tsukuba Research, Laboratories 1-3 Tokodai 5-chome Tsukuba-shi, Ibaraki / JP | 10 /
SORIMACHI, Keiichi c/o Eisai Co., Ltd. Tsukuba Research, Laboratories 1-3 Tokodai 5-chome Tsukuba-shi, Ibaraki / JP | 11 /
NAOE, Yoshimitsu c/o Eisai Co., Ltd. Tsukuba Research, Laboratories 1-3 Tokodai 5-chome Tsukuba-shi, Ibaraki / JP | 12 /
KAZUTA, Yuji c/o Eisai Co., Ltd. Tsukuba Research, Laboratories 1-3 Tokodai 5-chome Tsukuba-shi, Ibaraki / JP | [2014/52] | Representative(s) | HGF 1 City Walk Leeds LS11 9DX / GB | [N/P] |
Former [2019/14] | HGF Limited 1 City Walk Leeds LS11 9DX / GB | ||
Former [2014/52] | HGF Limited Belgrave Hall Belgrave Street Leeds LS2 8DD / GB | Application number, filing date | 13706874.8 | 14.02.2013 | [2019/14] | WO2013US26204 | Priority number, date | US201261600109P | 17.02.2012 Original published format: US 201261600109 P | [2014/52] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013123240 | Date: | 22.08.2013 | Language: | EN | [2013/34] | Type: | A1 Application with search report | No.: | EP2814798 | Date: | 24.12.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 22.08.2013 takes the place of the publication of the European patent application. | [2014/52] | Type: | B1 Patent specification | No.: | EP2814798 | Date: | 03.04.2019 | Language: | EN | [2019/14] | Search report(s) | International search report - published on: | EP | 22.08.2013 | Classification | IPC: | C07C29/147, C07C303/28, C07D239/28, C12P41/00, C07C33/50, C07C309/70, C07D239/34, C07D401/12 | [2014/52] | CPC: |
C07C309/73 (EP,CN,RU,US);
C07C29/147 (EP,CN,RU,US);
C07C303/28 (EP,CN,RU,US);
C07C303/44 (US);
C07C309/66 (US);
C07C69/16 (RU,US);
C07D239/34 (EP,CN,RU,US);
C07D401/12 (EP,CN,US);
C12P7/22 (EP,CN,US);
C07B2200/07 (US);
C07C2601/02 (EP,CN,US);
C07C33/36 (RU);
| C-Set: |
C07C29/147, C07C33/50 (CN,EP,US);
C07C303/28, C07C309/73 (US,CN,EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/52] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | VERFAHREN UND VERBINDUNGEN ZUR SYNTHESE VON OREXIN-2-REZEPTOR-ANTAGONISTEN | [2014/52] | English: | METHODS AND COMPOUNDS USEFUL IN THE SYNTHESIS OF OREXIN-2 RECEPTOR ANTAGONISTS | [2014/52] | French: | PROCÉDÉS ET COMPOSÉS UTILES DANS LA SYNTHÈSE D'ANTAGONISTES DU RÉCEPTEUR 2 DE L'OREXINE | [2014/52] | Entry into regional phase | 02.09.2014 | National basic fee paid | 02.09.2014 | Designation fee(s) paid | 02.09.2014 | Examination fee paid | Examination procedure | 02.09.2014 | Examination requested [2014/52] | 28.04.2015 | Amendment by applicant (claims and/or description) | 06.10.2017 | Despatch of a communication from the examining division (Time limit: M04) | 10.01.2018 | Reply to a communication from the examining division | 07.02.2018 | Despatch of a communication from the examining division (Time limit: M04) | 21.05.2018 | Reply to a communication from the examining division | 02.11.2018 | Communication of intention to grant the patent | 07.02.2019 | Fee for grant paid | 07.02.2019 | Fee for publishing/printing paid | 07.02.2019 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 06.10.2017 | Opposition(s) | 06.01.2020 | No opposition filed within time limit [2020/11] | Fees paid | Renewal fee | 26.02.2015 | Renewal fee patent year 03 | 22.02.2016 | Renewal fee patent year 04 | 17.02.2017 | Renewal fee patent year 05 | 22.02.2018 | Renewal fee patent year 06 | 21.02.2019 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 03.04.2019 | AT | 03.04.2019 | CY | 03.04.2019 | CZ | 03.04.2019 | DK | 03.04.2019 | EE | 03.04.2019 | FI | 03.04.2019 | HR | 03.04.2019 | LT | 03.04.2019 | LV | 03.04.2019 | MC | 03.04.2019 | MK | 03.04.2019 | MT | 03.04.2019 | NL | 03.04.2019 | PL | 03.04.2019 | RO | 03.04.2019 | RS | 03.04.2019 | SE | 03.04.2019 | SI | 03.04.2019 | SK | 03.04.2019 | SM | 03.04.2019 | TR | 03.04.2019 | BG | 03.07.2019 | NO | 03.07.2019 | GR | 04.07.2019 | IS | 03.08.2019 | PT | 03.08.2019 | [2022/32] |
Former [2022/27] | AL | 03.04.2019 | |
AT | 03.04.2019 | ||
CY | 03.04.2019 | ||
CZ | 03.04.2019 | ||
DK | 03.04.2019 | ||
EE | 03.04.2019 | ||
FI | 03.04.2019 | ||
HR | 03.04.2019 | ||
LT | 03.04.2019 | ||
LV | 03.04.2019 | ||
MC | 03.04.2019 | ||
MT | 03.04.2019 | ||
NL | 03.04.2019 | ||
PL | 03.04.2019 | ||
RO | 03.04.2019 | ||
RS | 03.04.2019 | ||
SE | 03.04.2019 | ||
SI | 03.04.2019 | ||
SK | 03.04.2019 | ||
SM | 03.04.2019 | ||
TR | 03.04.2019 | ||
BG | 03.07.2019 | ||
NO | 03.07.2019 | ||
GR | 04.07.2019 | ||
IS | 03.08.2019 | ||
PT | 03.08.2019 | ||
Former [2020/49] | AL | 03.04.2019 | |
AT | 03.04.2019 | ||
CZ | 03.04.2019 | ||
DK | 03.04.2019 | ||
EE | 03.04.2019 | ||
FI | 03.04.2019 | ||
HR | 03.04.2019 | ||
LT | 03.04.2019 | ||
LV | 03.04.2019 | ||
MC | 03.04.2019 | ||
NL | 03.04.2019 | ||
PL | 03.04.2019 | ||
RO | 03.04.2019 | ||
RS | 03.04.2019 | ||
SE | 03.04.2019 | ||
SI | 03.04.2019 | ||
SK | 03.04.2019 | ||
SM | 03.04.2019 | ||
TR | 03.04.2019 | ||
BG | 03.07.2019 | ||
NO | 03.07.2019 | ||
GR | 04.07.2019 | ||
IS | 03.08.2019 | ||
PT | 03.08.2019 | ||
Former [2020/26] | AL | 03.04.2019 | |
AT | 03.04.2019 | ||
CZ | 03.04.2019 | ||
DK | 03.04.2019 | ||
EE | 03.04.2019 | ||
FI | 03.04.2019 | ||
HR | 03.04.2019 | ||
LT | 03.04.2019 | ||
LV | 03.04.2019 | ||
NL | 03.04.2019 | ||
PL | 03.04.2019 | ||
RO | 03.04.2019 | ||
RS | 03.04.2019 | ||
SE | 03.04.2019 | ||
SI | 03.04.2019 | ||
SK | 03.04.2019 | ||
SM | 03.04.2019 | ||
TR | 03.04.2019 | ||
BG | 03.07.2019 | ||
NO | 03.07.2019 | ||
GR | 04.07.2019 | ||
IS | 03.08.2019 | ||
PT | 03.08.2019 | ||
Former [2020/17] | AL | 03.04.2019 | |
AT | 03.04.2019 | ||
CZ | 03.04.2019 | ||
DK | 03.04.2019 | ||
EE | 03.04.2019 | ||
FI | 03.04.2019 | ||
HR | 03.04.2019 | ||
LT | 03.04.2019 | ||
LV | 03.04.2019 | ||
NL | 03.04.2019 | ||
PL | 03.04.2019 | ||
RO | 03.04.2019 | ||
RS | 03.04.2019 | ||
SE | 03.04.2019 | ||
SK | 03.04.2019 | ||
SM | 03.04.2019 | ||
TR | 03.04.2019 | ||
BG | 03.07.2019 | ||
NO | 03.07.2019 | ||
GR | 04.07.2019 | ||
IS | 03.08.2019 | ||
PT | 03.08.2019 | ||
Former [2020/14] | AL | 03.04.2019 | |
AT | 03.04.2019 | ||
CZ | 03.04.2019 | ||
DK | 03.04.2019 | ||
EE | 03.04.2019 | ||
FI | 03.04.2019 | ||
HR | 03.04.2019 | ||
LT | 03.04.2019 | ||
LV | 03.04.2019 | ||
NL | 03.04.2019 | ||
PL | 03.04.2019 | ||
RO | 03.04.2019 | ||
RS | 03.04.2019 | ||
SE | 03.04.2019 | ||
SK | 03.04.2019 | ||
SM | 03.04.2019 | ||
BG | 03.07.2019 | ||
NO | 03.07.2019 | ||
GR | 04.07.2019 | ||
IS | 03.08.2019 | ||
PT | 03.08.2019 | ||
Former [2020/11] | AL | 03.04.2019 | |
AT | 03.04.2019 | ||
CZ | 03.04.2019 | ||
DK | 03.04.2019 | ||
EE | 03.04.2019 | ||
FI | 03.04.2019 | ||
HR | 03.04.2019 | ||
LT | 03.04.2019 | ||
LV | 03.04.2019 | ||
NL | 03.04.2019 | ||
PL | 03.04.2019 | ||
RO | 03.04.2019 | ||
RS | 03.04.2019 | ||
SE | 03.04.2019 | ||
SK | 03.04.2019 | ||
BG | 03.07.2019 | ||
NO | 03.07.2019 | ||
GR | 04.07.2019 | ||
IS | 03.08.2019 | ||
PT | 03.08.2019 | ||
Former [2020/10] | AL | 03.04.2019 | |
AT | 03.04.2019 | ||
CZ | 03.04.2019 | ||
DK | 03.04.2019 | ||
FI | 03.04.2019 | ||
HR | 03.04.2019 | ||
LT | 03.04.2019 | ||
LV | 03.04.2019 | ||
NL | 03.04.2019 | ||
PL | 03.04.2019 | ||
RO | 03.04.2019 | ||
RS | 03.04.2019 | ||
SE | 03.04.2019 | ||
BG | 03.07.2019 | ||
NO | 03.07.2019 | ||
GR | 04.07.2019 | ||
IS | 03.08.2019 | ||
PT | 03.08.2019 | ||
Former [2020/09] | AL | 03.04.2019 | |
AT | 03.04.2019 | ||
CZ | 03.04.2019 | ||
DK | 03.04.2019 | ||
FI | 03.04.2019 | ||
HR | 03.04.2019 | ||
LT | 03.04.2019 | ||
LV | 03.04.2019 | ||
NL | 03.04.2019 | ||
PL | 03.04.2019 | ||
RS | 03.04.2019 | ||
SE | 03.04.2019 | ||
BG | 03.07.2019 | ||
NO | 03.07.2019 | ||
GR | 04.07.2019 | ||
IS | 03.08.2019 | ||
PT | 03.08.2019 | ||
Former [2020/04] | AL | 03.04.2019 | |
AT | 03.04.2019 | ||
CZ | 03.04.2019 | ||
FI | 03.04.2019 | ||
HR | 03.04.2019 | ||
LT | 03.04.2019 | ||
LV | 03.04.2019 | ||
NL | 03.04.2019 | ||
PL | 03.04.2019 | ||
RS | 03.04.2019 | ||
SE | 03.04.2019 | ||
BG | 03.07.2019 | ||
NO | 03.07.2019 | ||
GR | 04.07.2019 | ||
IS | 03.08.2019 | ||
PT | 03.08.2019 | ||
Former [2020/03] | AL | 03.04.2019 | |
AT | 03.04.2019 | ||
CZ | 03.04.2019 | ||
FI | 03.04.2019 | ||
HR | 03.04.2019 | ||
LT | 03.04.2019 | ||
LV | 03.04.2019 | ||
NL | 03.04.2019 | ||
PL | 03.04.2019 | ||
RS | 03.04.2019 | ||
SE | 03.04.2019 | ||
BG | 03.07.2019 | ||
NO | 03.07.2019 | ||
GR | 04.07.2019 | ||
PT | 03.08.2019 | ||
Former [2019/52] | AL | 03.04.2019 | |
CZ | 03.04.2019 | ||
FI | 03.04.2019 | ||
HR | 03.04.2019 | ||
LT | 03.04.2019 | ||
LV | 03.04.2019 | ||
NL | 03.04.2019 | ||
PL | 03.04.2019 | ||
RS | 03.04.2019 | ||
SE | 03.04.2019 | ||
BG | 03.07.2019 | ||
NO | 03.07.2019 | ||
GR | 04.07.2019 | ||
PT | 03.08.2019 | ||
Former [2019/51] | AL | 03.04.2019 | |
CZ | 03.04.2019 | ||
FI | 03.04.2019 | ||
HR | 03.04.2019 | ||
LT | 03.04.2019 | ||
LV | 03.04.2019 | ||
NL | 03.04.2019 | ||
RS | 03.04.2019 | ||
SE | 03.04.2019 | ||
BG | 03.07.2019 | ||
NO | 03.07.2019 | ||
GR | 04.07.2019 | ||
PT | 03.08.2019 | ||
Former [2019/50] | AL | 03.04.2019 | |
CZ | 03.04.2019 | ||
FI | 03.04.2019 | ||
HR | 03.04.2019 | ||
LT | 03.04.2019 | ||
LV | 03.04.2019 | ||
NL | 03.04.2019 | ||
RS | 03.04.2019 | ||
SE | 03.04.2019 | ||
NO | 03.07.2019 | ||
GR | 04.07.2019 | ||
PT | 03.08.2019 | ||
Former [2019/49] | AL | 03.04.2019 | |
CZ | 03.04.2019 | ||
FI | 03.04.2019 | ||
HR | 03.04.2019 | ||
LT | 03.04.2019 | ||
NL | 03.04.2019 | ||
SE | 03.04.2019 | ||
NO | 03.07.2019 | ||
PT | 03.08.2019 | ||
Former [2019/48] | FI | 03.04.2019 | |
LT | 03.04.2019 | ||
NL | 03.04.2019 | ||
SE | 03.04.2019 | ||
NO | 03.07.2019 | ||
PT | 03.08.2019 | ||
Former [2019/47] | FI | 03.04.2019 | |
LT | 03.04.2019 | ||
NL | 03.04.2019 | ||
NO | 03.07.2019 | ||
Former [2019/44] | NL | 03.04.2019 | Cited in | International search | [I]WO2008057575 (DOV PHARMACEUTICAL INC [US], et al) [I] 1 * page 97, line 15 - page 99, line 12 *; | [A]WO2008150364 (MERCK & CO INC [US], et al) [A] 1-139* the whole document *; | [X] - KAZUYA YAMAGUCHI ET AL, "Construction of a cis-Cyclopropane via Reductive Radical Decarboxylation. Enantioselective Synthesis of cis- and trans-1-Arylpiperazyl-2-phenylcyclopropanes Designed as Antidopaminergic Agents", JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY, (20030611), vol. 68, no. 24, doi:10.1021/JO0302206, pages 9255 - 9262, XP002512742 [X] 1 * scheme 2 * * page 9260, column 1, paragraph 3 * DOI: http://dx.doi.org/10.1021/JO0302206 | [X] - VALGIMIGLI L ET AL, "THE EFFECT OF RING NITROGEN ATOMS ON THE HOMOLYTIC REACTIVITY OF PHENOLIC COMPOUNDS: UNDERSTANDING THE RADICAL-SCAVENGING ABILITY OF 5-PYRIMIDINOLS", CHEMISTRY - A EUROPEAN JOURNAL, WILEY - V C H VERLAG GMBH & CO. KGAA, WEINHEIM, DE, (20031017), vol. 9, no. 20, doi:10.1002/CHEM.200304960, ISSN 0947-6539, pages 4997 - 5010, XP009062482 [X] 84 * page 4998, column 1, last 4 lines to column 2, first 2 lines * * page 5007, column 1, paragraph 4 * DOI: http://dx.doi.org/10.1002/chem.200304960 | by applicant | US7189715 | US2012009659 | US8101643 | - SAKURAI T. ET AL., CELL, (1998), vol. 92, pages 573 - 585 | - CHEMELLI R.M. ET AL., CELL, (1999), vol. 98, pages 437 - 451 | - S.L. BORGLAND ET AL., NEURON, (2006), vol. 49, pages 598 - 601 | - C.J. WINROW ET AL., NEUROPHARMACOLOGY, (2010), vol. 58, pages 185 - 194 | - J.R. SHOBLOCK ET AL., PSYCHOPHARMACOLOGY, (2011), vol. 215, pages 191 - 203 | - T. IDA ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., (2000), vol. 270, pages 318 - 323 | - NAKATA ET AL., TETT. LETT., (1983), vol. 24, pages 2653 - 56 |